Company intelligence / Profile preview

Dipharma

Baranzate, Lombardia, Italy

Ownership: Private
Employees: ~550
Development stage: Other

Overview

Dipharma is a global and long-established CDMO and API manufacturer with a reputation for safety, regulatory compliance, and innovation, operating four cGMP plants; it supplies APIs and intermediates globally, primarily for generic and contract manufacturing markets, with a particular skill in handling hazardous chemistries

Therapeutic areas: Metabolic Disorders
Modalities: Small moleculeGeneric drugs
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Dipharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dipharma.

Explore the full profile